Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03574974 · ClinicalTrials.gov registry record · NA
Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03574974 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 27 participants.
The verdict
NCT03574974, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The primary purpose of this study is to investigate the efficacy of neurofeedback (NF) of real-time functional magnetic resonance imaging (rt-fMRI) data of the amygdala with regards to the reduction of post-traumatic stress disorder (PTSD) symptoms. A secondary purpose of this study is to use fMRI as a method of investigating brain function in individuals with PTSD. This study approach provides a tool for probing the neurobiology of PTSD by (1) testing the critical role of the amygdala in this disorder, and by (2) examining how amygdala connectivity is related to both amygdala regulation and clinical symptoms.
Interventions
- DEVICE Experimental Feedback
- DEVICE Control Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2022-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03574974
The ClinicalTrials.gov registry entry for NCT03574974 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental Feedback is the first listed.
NCT03574974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03574974 about?
NCT03574974 is a clinical study titled "Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder". The primary purpose of this study is to investigate the efficacy of neurofeedback (NF) of real-time functional magnetic resonance imaging (rt-fMRI) data of the amygdala with regards to the reduction of post-traumatic stress disorder (PTSD) symptoms. A secondary purpose of this study is to use fMRI ...
What is the current status of trial NCT03574974?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2018-06-01. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT03574974?
The interventions under investigation include: Experimental Feedback (DEVICE), Control Feedback (DEVICE).
Who is sponsoring clinical trial NCT03574974?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.